Indian Pharma Network – Buy prescriptions drugs

18008891064
info@indianpharmanetwork.in

Facebook Twitter Linkedin Whatsapp

logo_pharma

Menu

Home
About Us
Product List
Blog
Support & FAQs
News
Contact Us

Search

Close

Monthly Archives

January 2023

Drug & Cosmetic Act And Rules

Breast Cancer Drug & Cosmetic Act

Drug & Cosmetic Act And Rules: INDIA

Triple-Negative-Breast-Cancer

Breast Cancer

Triple Negative Breast Cancer (TNBC)

Indication-Tuksya-a-kinase-inhibitor

Metastatic Breast Cancer metastatic colorectal cancer

Indication: Tukysa, a kinase inhibitor

Acute Lymphoblastic Leukemia

acute lymphocytic leukemia

Analysis of Acute Lymphoblastic Leukemia Treatment

Monjuvi RR-DLBCL

DLBCL

Monjuvi the Newest Blockbuster in RR DLBCL

Metastatic Breast Cancer

Metastatic Breast Cancer

Metastatic Breast Cancer Treatment Options available

name patient import

name patient import

Named Patient Import Program in India

Related Posts

Drug & Cosmetic Act And Rules

Drug & Cosmetic Act...

What are the Drug &...

Supplying Hard-to-Find Imported Medicines...

In today’s world, easy access...

Ponatinib Shines as Induction...

In the realm of Chronic...

Cystathionine Beta-Synthase (CBS) Deficiency

Cystathionine Beta-Synthase (CBS) Deficiency:...

Cystathionine beta-synthase (CBS) deficiency, also...

Non-small cell lung cancer...

In the realm of targeted...

Recent Posts

Trientine Hydrochloride: Uses, Safety, and Patient Care
Symptoms and Diagnosis of Wilson’s Disease
The Role of Encorafenib in BRAF-Positive Advanced Cancers
What You Should Know Before Receiving Trodelvy: Medical Conditions, Allergies, and Potential Side Effects
FDA Approves Gene Therapy for Wiskott–Aldrich Syndrome

Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import

INDIA PHARMA NETWORK

Home
About Us
News
Blog
Contact Us

TOP IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India

CORPORATE OFFICE

Indian Pharma Network.
905-9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
info@indianpharmanetwork.in

GET IN TOUCH

Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.

Facebook Whatsapp Twitter Linkedin Pinterest

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India
Polivy in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer

TOP ARTICLES

Eculizumab
HMPV
aHUS
PNH
Melanoma
PAH

PBC
MPOX Virus
Counterfeit Drugs
Nelarabine Injections
Polivy
Trodelvy

FDA DRUG APPROVALS 2025

Journavx
symbravo
Grafapex
Romvimza
Alhemo

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Trientine in India
Blincyto in India
vyloy in India
Orencia in India
Welireg in India

Kineret in India
Retevmo in India
Lazcluze in india
Trientine Availability
Imdeltra In India
Krazati in India
Lytgobi in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Wilson’s Disease

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer
Duchenne Muscular Dystrophy

TOP ARTICLES

Eculizumab
HMPV
aHUS
PNH
Melanoma
PAH
Trodelvy

PBC
MPOX Virus
Counterfeit Drugs
Nelarabine
Polivy

FDA Drug Approvals

Lumakras
Gavreto
symbravo
Grafapex
Romvimza
Alhemo
Zepzelca
Agilus

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza
Columvi
Rinvoq
Lazcluze

Latest News

Trusted Global Supplier from India
Takeda’s Qdenga Vaccine
Manufacture Risdiplam for (SMA)
FDA Approves Qfitlia (Fitusiran) for Hemophilia
Wilson’s Disease: Neurological Symptoms, Early Signs, and Treatment Options

Indian Pharma Network

Indian Pharma Network Tower A 905, I-Thum Business Park, Block A, Sector 62, Noida, Uttar Pradesh 201301

Mission Vision and value

Mobile/WhatsApp/Phone

M: +91 9654860915
M: +91 9310090915

Free Customer Support

info@indianpharmanetwork.in

Disclaimer : Website: indianpharmanetwork.in is a pharmaceutical trading entity that procures and supplies prescribed medicines strictly from manufacturers or duly authorized distributors. The company does not manufacture, formulate, or alter any pharmaceutical products. All trademarks, brand names, and product names referenced remain the property of their respective owners. Any use of such names is solely for identification purposes and is in compliance with the provisions of the Trademark Act, 1999, including principles of fair use. Website: indianpharmanetwork.in does not claim ownership of, nor does it assert any rights over, any patents associated with the products supplied. Compliance with patent laws, including the Patents Act, 1970, rests with the respective patent holders, manufacturers, or marketing authorization holders. The company facilitates access to certain medicines, including new launches, through legally permissible channels such as named patient import, strictly against valid prescriptions and in accordance with applicable laws and regulatory requirements. Nothing herein shall be construed as an inducement or authorization to infringe any intellectual property rights.

© 2026 Indian Pharma Network - Buy prescriptions drugs.

How can I Help You?

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.